Antibiotic prescription and cost patterns in a general intensive care unit
Norberto Krivoy1, Wissam Abed El-Ahal1, Yaron Bar-Lavie2, Salim Haddad3
- 1Division of Medicine, Clinical Pharmacology Unit, Rambam Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, ISRAEL.
- 2General Intensive Care Unit, Rambam Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, ISRAEL.
- 3Pharmacy Service, Rambam Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, ISRAEL.
Volume 5, Issue 2 · pp. 67–73 · PUBLISHED 2007 · DOI:
ABSTRACT
Aim/Background: Antibiotic prescription habits, cost pattern, and the prospective intervention in an Intensive Care Unit were analyzed. Materials and Methods: Data on antibiotic utilization and costs were collected prospectively from individual electronic charts from August 2003 to January 2004, and retrospectively from August to December 2002. Results: A total of 180 and 107 patients were surveyed in 2002 and 2003. In 2002, Piperacillin-Tazobactam (13.8%) and Imipenem/Cilastin (11.2%) were the most prescribed medications; while, in 2003, Vancomycin (12.6%) and Imipenem/Cilastin (11.3%) were prescribed, respectively. Total defined daily dose (DDD) and Drug Utilization 90% (DU90%) index for 2002 and 2003 were 2031.15 and 2325.90 DDDs (p>0.1) and 1777.57 and 2079.61 DU90%, respectively (p>0.1). The Median Total Cost /100 admission days (CI 95%) were NIS13,310 (11,110;18,420) and NIS13,860 (6,710;18,020) (p=0.66), respectively. Conclusion: Interventional programs should focus on promoting infectious control with rational antibiotic prescription aimed at minimizing the future emergence of bacterial resistance and futile expenses.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Krivoy, N., El-Ahal, W. A., Bar-Lavie, Y., & Haddad, S. (2007). Antibiotic prescription and cost patterns in a general intensive care unit. Pharmacy Practice, 5(2), 67–73.
